KMS Medisurgi Limited , a company listed on the BSE SME platform, has announced its financial results for the half-year ended September 30. The company reported a profit of Rs 29.63 lacs, with revenue from operations standing at Rs 661.66 lacs.

Financial Highlights

The company's performance shows a slight decrease compared to the previous half-year, where it reported a profit of Rs 36.10 lacs.

Balance Sheet Overview

As of September 30, KMS Medisurgi's balance sheet reflects the following:

Auditor's Observations

The company's auditors, H H Dedhia & Associates, have highlighted two areas of concern in their limited review report:

1. Employee Benefit Accounting: The auditors noted that the company's method of accounting for post-employment benefits and other long-term employee benefits under defined benefit plans deviates from AS-15 on Employee Benefits. The quantum of this deviation could not be ascertained due to the lack of an actuarial report.

2. Inventory Valuation: The closing stock, valued at Rs 295.45 lacs, has been physically verified and valued by the management. However, the auditors were unable to comment on the movement of stock and the accuracy of this value due to ongoing reconciliation processes.

Management's Response

The company's management, led by Managing Director Siddharth Kanakia, has acknowledged these points and is working on addressing them. They have stated that the company is in the process of reconciling stock records with books of accounts.

Market Implications

While KMS Medisurgi has shown profitability, the auditor's observations may raise some concerns among investors. The company's ability to address these issues in the coming months could be crucial for maintaining investor confidence.

It's important to note that as a company listed on the BSE SME platform, KMS Medisurgi is exempt from certain regulatory requirements, including the adoption of IND-AS for financial reporting.

Investors and stakeholders are advised to consider both the financial performance and the auditor's observations when evaluating the company's overall position.

KMS Medisurgi Limited has announced its 27th Annual General Meeting (AGM) and several key corporate actions, signaling important developments for shareholders.

AGM Date and Venue

The company's Board of Directors has approved holding the 27th AGM on Tuesday, September 30, 2025, at 3:00 PM. The meeting will take place at the company's registered office located at 297/301 May Building, Ground Floor, Marine Lines (East), Princess Street, Mumbai-400002.

Dividend Recommendation

In a move that may interest shareholders, the Board has recommended a final dividend of Rs 0.05 (0.5%) per equity share for the financial year ended March 31, 2025. This dividend is subject to shareholder approval at the upcoming AGM.

Record Date and Book Closure

KMS Medisurgi has set Tuesday, September 23, 2025, as the 'Record Date' for determining shareholders eligible to receive the dividend. The Register of Members and Share Transfer Books will remain closed from Wednesday, September 24, 2025, to Tuesday, September 30, 2025 (both days inclusive).

Key Agenda Items

The AGM will address several important matters, including:

1. Adoption of financial statements for FY 2024-25
2. Declaration of the final dividend
3. Re-appointment of Mr. Gaurang Kanakia (DIN: 00346180) as a Director, who retires by rotation
4. Appointment of Secretarial Auditors

Appointment of Secretarial Auditors

The Board has recommended the appointment of M/s. Naveen Karn & Co., Practising Company Secretaries, as Secretarial Auditors for a term of five consecutive years from FY 2025-26 to FY 2029-30. This appointment is subject to shareholder approval at the AGM.

E-voting Information

To facilitate shareholder participation, the company has arranged e-voting services through KfinTech. Shareholders can cast their votes electronically from Saturday, September 27, 2025 (9:00 AM) to Monday, September 29, 2025 (5:00 PM).

Corporate Governance Measures

KMS Medisurgi has appointed M/s. Naveen Karn & Associates as the scrutinizer to oversee the e-voting process, ensuring transparency and fairness in the voting procedure.

Shareholders are encouraged to review the detailed AGM notice and participate in the upcoming meeting to stay informed about the company's affairs and exercise their voting rights on crucial matters.